Journal of Medicinal Chemistry · 2014 · 48 citations · 16 references
PharmacyMedicinal ChemistryPharmacologyBioavailabilityDrug DesignDrug DiscoveryIn Vitro PharmacologyStructure-activity Relationship AnalysisDrug Candidate OptimizationHigh-throughput Screening AssaysOral Absorption AssessmentOral Drug BioavailabilityPharmacokinetic ScreeningPharmacological ScreeningStructure - Activity Relationship OptimizationWhole-cell Screening
A novel class of imidazopyridazines identified from whole cell screening of a SoftFocus kinase library was synthesized and evaluated for antiplasmodial activity against K1 (multidrug resistant strain) and NF54 (sensitive strain). Structure-activity relationship studies led to the identification of highly potent compounds against both strains. Compound 35 was highly active (IC50: K1 = 6.3 nM, NF54 = 7.3 nM) and comparable in potency to artesunate, and 35 exhibited 98% activity in the in vivo P. berghei mouse model (4-day test by Peters) at 4 × 50 mg/kg po. Compound 35 was also assessed against P. falciparum in the in vivo SCID mouse model where the efficacy was found to be more consistent with the in vitro activity. Furthermore, 35 displayed high (78%) rat oral bioavailability with good oral exposure and plasma half-life. Mice exposure at the same dose was 10-fold lower than in rat, suggesting lower oral absorption and/or higher metabolic clearance in mice.
16
Artemisinin Resistance in <i>Plasmodium falciparum</i> Malaria
Arjen M. Dondorp, François Nosten, Poravuth Yi et al. · New England Journal of Medicine · 2009 · 3.5K citations · Full text
R. Scott Obach · Drug Metabolism and Disposition · 1999 · 1.2K citations
Targeting Plasmodium PI(4)K to eliminate malaria
Case W. McNamara, Chek Shik Lim, Siau Hoi Lim et al. · Nature · 2013 · 426 citations · Full text
Marı́a Belén Jiménez-Dı́az, Teresa Mulet, Sara Viera et al. · Antimicrobial Agents and Chemotherapy · 2009 · 189 citations · Full text
Medicine, Immunology, Pharmacology +16